Article Text

Download PDFPDF
A low-grade follicular lymphoma with strong expression of cyclin D1, but without evidence of CCND1 translocation or amplification
  1. Zbigniew Rudzki1,
  2. Terence Jones2,
  3. Jane Starczynski1,
  4. Fiona Clark3
  1. 1 Department of Cellular Pathology, Birmingham Heartlands Hospital, Heart of England NHS, Foundation Trust, Birmingham, UK
  2. 2 Department of Histopathology, Royal Shrewsbury Hospital, The Shrewsbury and Telford Hospital NHS Trust, Shrewsbury, UK
  3. 3 Department of Haematology, Worcestershire Royal Hospital, Worcestershire Acute Hospitals NHS Trust, Worcester, UK
  1. Correspondence to Dr Zbigniew Rudzki, Department of Cellular Pathology, Birmingham Heartlands Hospital, Heart of England NHS, Foundation Trust, Bordesley Green East, Birmingham B9 5SS, UK; zbigniew.rudzki{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Aberrant immunophenotypes break classification rules, cause diagnostic uncertainties and may contribute to therapeutic dilemmas. An unusual case of cyclin D1-positive follicular lymphoma published recently in this journal showed a three-way translocation involving IgH, BCL2 and CCND1 genes.1 We present a case of a true low-grade follicular lymphoma expressing cyclin D1, without evidence of the CCND1 translocation. Confusingly, an incidental unrelated Cyclin D1-positive plasma cell clone was discovered on bone marrow staging.

A 77-year-old male patient presented with dysphagia due to large right tonsillary enlargement. He was well without B symptoms. His peripheral blood counts, serum calcium and renal function were normal. CT of the neck, chest, abdomen and pelvis showed no lymphadenopathy or other organomegaly. An IgG κ paraprotein of 10.8 g/l was demonstrated, with mild immune paresis (IgA 0.72 g/l, IgM 0.38 g/l) and abnormal serum-free light chains (κ 49.93 mg/l, λ 6.53 mg/l). Skeletal survey showed no lytic lesions.

The excised right tonsil was packed by lymphoid follicles dominated by centrocytes mixed with few centroblasts, expressing CD20, PAX5, CD10, BCL6, BCL2 and λ and negative for CD3, CD5 and CD43 and κ (figure 1A–D). Surprisingly, most centrocytes and centroblasts were also positive for cyclin D1 (figure 1E,F). Expression of cyclin D1 followed patterns seen for CD10 and BCL6, including focal spillage of positive cells outside confines of follicles. Additionally, there were a few neoplastic follicles at the margin of the tonsil, which had features reminiscent of the in situ pattern of follicular lymphoma, featuring better preserved mantle zones, surrounding smaller germinal centres composed …

View Full Text


  • Contributors ZR made the final diagnosis, initiated writing the case report, wrote the draft of the article and made photographs of routine histology and immunohistochemistry. TJ made the preliminary diagnosis, referred the case to ZR and reviewed the manuscript. JS performed and interpreted the molecular studies, made FISH photographs and discussed the manuscript. FC provided the clinical data, and cowrote the manuscript.

  • Competing interests None.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.